Step by step. The benefits of stage-based R&D licensing contracts

被引:22
|
作者
Crama, Pascale [1 ]
De Reyck, Bert [2 ]
Degraeve, Zeger [3 ,4 ]
机构
[1] Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178899, Singapore
[2] UCL, Dept Management Sci & Innovat, London WC1E 6BT, England
[3] Melbourne Business Sch, Melbourne, Vic 3053, Australia
[4] London Business Sch, Dept Management Sci & Operat, London NW1 4SA, England
关键词
Research and development; Innovation; Contract design; Asymmetric information; Industries; Pharmaceutical; MANAGEMENT; INNOVATION; DESIGN; RISK;
D O I
10.1016/j.ejor.2012.09.014
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
We examine how a licensor can optimally design licensing contracts for multi-phase R&D projects when he does not know the licensee's project valuation, leading to adverse selection, and cannot enforce the licensee's effort level, resulting in moral hazard. We focus on the effect of the phased nature typical of such projects, and compare single-phase and multi-phase contracts. We determine the optimal values for the upfront payment, milestone payments and royalties, and the optimal timing for outlicensing. Including multiple milestones and accompanying payments can be an effective way of discriminating between licensees holding different valuations, without having to manipulate the royalty rate, which induces licensees to invest less, resulting in lower project values and socially suboptimal solutions. Interestingly, we also find that multiple milestone payments are beneficial even when the licensor is risk-averse, contrary to standard contract theory results, which recommend that only an upfront payment should be used. In terms of licensing timing, we show that the optimal time depends on the licensor's risk aversion, the characteristics of the licensee and the project value. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:572 / 582
页数:11
相关论文
共 50 条
  • [21] What drives researchers to engage in R&D contracts
    Sofia Olaya-Escobar, Erika
    Berbegal-Mirabent, Jasmina
    German Duarte-Velasco, Oscar
    [J]. TEC EMPRESARIAL, 2021, 15 (03): : 18 - 36
  • [22] The Optimization of Multitask Incentive Contracts of R&D Personnel
    Zhong He-ping
    [J]. PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON RISK MANAGEMENT & ENGINEERING MANAGEMENT, VOLS 1 AND 2, 2008, : 886 - 890
  • [23] From R&D to licensing - What to do and when to do it
    Sofer, G
    [J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (01): : 18 - +
  • [24] Milestone Payments or Royalties? Contract Design for R&D Licensing
    Crama, Pascale
    De Reyck, Bert
    Degraeve, Zeger
    [J]. OPERATIONS RESEARCH, 2008, 56 (06) : 1539 - 1552
  • [25] R&D Licensing agreement to develop a new mastitis vaccine
    不详
    [J]. VETERINARY RECORD, 2016, 178 (24) : 604 - 604
  • [26] Believe It or Not: Strategic Licensing Makes R&D Alliance Profitable
    Banerjee, Tannista
    Sengupta, Aditi
    [J]. B E JOURNAL OF ECONOMIC ANALYSIS & POLICY, 2019, 19 (04):
  • [27] Patents, imitation and licensing in an asymmetric dynamic R&D race
    Fershtman, Chaim
    Markovich, Sarit
    [J]. INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION, 2010, 28 (02) : 113 - 126
  • [28] Fee versus Royalty Licensing in an Endogenous R&D Model
    Lee, J. Y.
    Lu, C. M.
    Tsai, C. S.
    Huang, C. S.
    [J]. 2009 IEEE 16TH INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT, VOLS 1 AND 2, PROCEEDINGS, 2009, : 1983 - +
  • [29] Incumbency and R&D incentives: Licensing the gale of creative destruction
    Gans, JS
    Stern, S
    [J]. JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 2000, 9 (04) : 485 - 511
  • [30] ESTIMATING THE BENEFITS OF TARGETED R&D SUBSIDIES
    Takalo, Tuomas
    Tanayama, Tanja
    Toivanen, Otto
    [J]. REVIEW OF ECONOMICS AND STATISTICS, 2013, 95 (01) : 255 - 272